Published in Clin J Pain on February 01, 2012
A multicenter, primary care-based, open-label study to identify behaviors related to prescription opioid misuse, abuse, and diversion in opioid-experienced patients with chronic moderate-to-severe pain. J Pain Res (2015) 0.82
Factors Associated with Opioid Use in a Cohort of Patients Presenting for Surgery. Pain Res Treat (2015) 0.77
Opioid misuse behaviors in adolescents and young adults in a hematology/oncology setting. J Pediatr Psychol (2014) 0.76
The Contribution of Differential Opioid Responsiveness to Identification of Opioid Risk in Chronic Pain Patients. J Pain (2015) 0.75
Clinical guidelines for the use of chronic opioid therapy in chronic noncancer pain. J Pain (2009) 9.36
Cancer-associated stromal fibroblasts promote pancreatic tumor progression. Cancer Res (2008) 5.21
An analysis of the root causes for opioid-related overdose deaths in the United States. Pain Med (2011) 2.39
Transformation of acute cancer pain to chronic cancer pain syndromes. J Support Oncol (2012) 2.08
Challenges in using opioids to treat pain in persons with substance use disorders. Addict Sci Clin Pract (2008) 1.81
Distress screening in a multidisciplinary lung cancer clinic: prevalence and predictors of clinically significant distress. Lung Cancer (2006) 1.67
Recommendations for urine drug monitoring as a component of opioid therapy in the treatment of chronic pain. Pain Med (2012) 1.53
An open-label, crossover trial of mirtazapine (15 and 30 mg) in cancer patients with pain and other distressing symptoms. J Pain Symptom Manage (2002) 1.50
Challenges in the development of prescription opioid abuse-deterrent formulations. Clin J Pain (2007) 1.48
A phase II trial of olanzapine for the prevention of chemotherapy-induced nausea and vomiting: a Hoosier Oncology Group study. Support Care Cancer (2005) 1.18
Seeking drug treatment for OxyContin abuse: a chart review of consecutive admissions to a substance abuse treatment facility in Kentucky. J Natl Compr Canc Netw (2003) 1.12
Abuse and addiction issues in medically ill patients with pain: attempts at clarification of terms and empirical study. Clin J Pain (2002) 1.05
A comparison of common screening methods for predicting aberrant drug-related behavior among patients receiving opioids for chronic pain management. Pain Med (2009) 1.01
Management of chronic noncancer pain in the primary care setting. South Med J (2007) 1.00
Brief report: pain and readiness to quit smoking cigarettes. Nicotine Tob Res (2006) 1.00
Assessment of quality of life in outpatients with advanced cancer: the accuracy of clinician estimations and the relevance of spiritual well-being--a Hoosier Oncology Group Study. J Clin Oncol (2003) 0.98
A phase II trial of olanzapine, dexamethasone, and palonosetron for the prevention of chemotherapy-induced nausea and vomiting: a Hoosier oncology group study. Support Care Cancer (2007) 0.98
Assessing self-efficacy for coping with cancer: development and psychometric analysis of the brief version of the Cancer Behavior Inventory (CBI-B). Psychooncology (2011) 0.98
Reported lifetime aberrant drug-taking behaviors are predictive of current substance use and mental health problems in primary care patients. Pain Med (2008) 0.97
Substance abuse in cancer pain. Curr Pain Headache Rep (2010) 0.89
Current status and evolving role of abuse-deterrent opioids in managing patients with chronic pain. J Opioid Manag (2011) 0.89
Difficulties in screening for adjustment disorder, Part I: Use of existing screening instruments in cancer patients undergoing bone marrow transplantation. Palliat Support Care (2004) 0.88
Initial development of a survey tool to detect issues of chemical coping in chronic pain patients. Palliat Support Care (2007) 0.88
My mind is as clear as it used to be: A pilot study illustrating the difficulties of employing a single-item subjective screen to detect cognitive impairment in outpatients with cancer. J Pain Symptom Manage (2003) 0.86
Palliative care of the terminally ill drug addict. Cancer Invest (2006) 0.84
Attentional bias for prescription opioid cues among opioid dependent chronic pain patients. J Behav Med (2012) 0.84
An opioid screening instrument: long-term evaluation of the utility of the pain medication questionnaire by Holmes et al. Pain Pract (2006) 0.84
Pain and addiction interface. Pain Med (2008) 0.80
A pilot study to examine the relationship between boredom and spirituality in cancer patients. Palliat Support Care (2003) 0.80
Substance abuse issues in cancer pain. Curr Pain Headache Rep (2002) 0.80
Difficulties in screening for adjustment disorder, Part II: An attempt to develop a novel self-report screening instrument in cancer patients undergoing bone marrow transplantation. Palliat Support Care (2004) 0.78
Hospice staff members' views on conducting end-of-life research. Palliat Support Care (2004) 0.77
Treatment of breakthrough pain with fentanyl buccal tablet in opioid-tolerant patients with chronic pain: appropriate patient selection and management. Pain Med (2010) 0.77
An open label pilot study of citalopram for depression and boredom in ambulatory cancer patients. Palliat Support Care (2003) 0.77
Chronic opioid therapy issues associated with opioid abuse potential. J Opioid Manag (2009) 0.77
Gender differences in the mediated relationship between alcohol use and academic motivation among late adolescents. Am J Orthopsychiatry (2007) 0.77
Frequency, characteristics, and correlates of pain in a pilot study of colorectal cancer survivors 1-10 years post-treatment. Pain Med (2013) 0.77
Preliminary data on a new opioid risk assessment measure: the Brief Risk Interview. J Opioid Manag (2013) 0.77
Re. Probing the paradox of patients' satisfaction with inadequate pain management. J Pain Symptom Manage (2002) 0.76
Development of a Faith-Based Stress Management Intervention in a Rural African American Community. Prog Community Health Partnersh (2015) 0.75
Effects of a single session group intervention for pain management in chronic pain patients: a pilot study. Pain Ther (2013) 0.75
Opioid rotation: what is the rush? Pain Med (2012) 0.75
PMPs and Rx drug abuse--encouraging signs but is it every man for himself? Pain Med (2012) 0.75
Prescribing opioids for chronic noncancer pain in primary care: risk assessment. Postgrad Med (2014) 0.75
A Survey of ASAM Members' Knowledge, Attitudes, and Practices in Urine Drug Testing. J Addict Med (2015) 0.75
A pilot study of the impact of a grief camp for children. Palliat Support Care (2004) 0.75
Clinicians' perspective on the use of immunoassay versus definitive laboratory quantitation methodologies for medication monitoring. J Pain Palliat Care Pharmacother (2014) 0.75
Same as it ever was? Life after the OxyContin media frenzy. J Pain Symptom Manage (2003) 0.75
Erratum to: Effects of a Single Session Group Intervention for Pain Management in Chronic Pain Patients: A Pilot Study. Pain Ther (2013) 0.75
Who gets blamed for intimate partner violence? The relative contributions of perpetrator sex category, victim confrontation, and observer attitudes. J Interpers Violence (2012) 0.75
King of pain: what Elvis's death tells us about media coverage of celebrities and the pain/addiction interface. J Opioid Manag (2007) 0.75
A chart review, pilot study of two single-item screens to detect cancer patients at risk for cachexia. Palliat Support Care (2003) 0.75
Substance abuse issues in oral and maxillofacial practice. Oral Maxillofac Surg Clin North Am (2010) 0.75
Risks and responsibilities in prescribing opioids for chronic noncancer pain, part 2: best practices. Postgrad Med (2014) 0.75
Definitive LC-MS/MS Drug Monitoring Impacts Substance-use Treatment Planning and Patient Outcomes: A Brief Report. J Addict Med (2016) 0.75
A comparison of methods of administering the opioid risk tool. J Opioid Manag (2011) 0.75
Exploring rates of abnormal pharmacogenetic findings in a pain practice. J Pain Palliat Care Pharmacother (2014) 0.75
Management of human papillomavirus-related anal and colon cancer. Curr Probl Dermatol (2014) 0.75
Defective DNA mismatch repair activity is common in sebaceous neoplasms, and may be an ineffective approach to screen for Lynch syndrome. Fam Cancer (2015) 0.75
Screening for abuse risk in pain patients. Adv Psychosom Med (2011) 0.75